Products
Fixed Combination Drug Products
Inflabloc Pharmaceutical’s main
focus is developing fixed combination drug products that incorporate DHEA
as a primary active ingredient. There are many therapeutic benefits of a DHEA
combination product:
- Patients who are unable to achieve
treatment goals with monotherapeutic drugs, may achieve them with DHEA combination
product
- Patients who are at risk for
intolerance, toxicity, or adverse drug interactions with a higher dose of
monotherapeutic drugs, may reduce side effects with DHEA combination product
- DHEA combination products may
target multiple mechanisms of action to yield synergistic improvements
- Combination products are more
convenient and give greater patient compliance than the individual products
taken concomitantly
From
a business standpoint, development of DHEA combination products offers several
advantages including a significant potential to address unmet therapeutic needs,
opening up new market opportunities, and extending patent life.
Click
on "Product" or "Indication" for additional information.
Product
Pipeline
Inflabloc's product line contains
three proprietary DHEA combinations that are currently being developed as
treatments for gastrointestinal disorders as well as other inflammatory diseases.
©
Copyright 2004. Inflabloc Pharmaceuticals, Inc.. All Rights Reserved.
